EDIL3 and breast carcinoma: Recent studies also suggest that exosomal human epidermal growth factor receptor 2 (HER2) (8–10), developmental endothelial locus 1 (Del-1) (11, 12), and fibronectin (13) can serve as biomarkers in breast cancer detection.